Biol Reprod Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print June 30, 2004.
Biol Reprod 2004, 10.1095/biolreprod.104.032086
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
71/5/1475    most recent
biolreprod.104.032086v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Penchalaneni, J.
Right arrow Articles by Yallampalli, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Penchalaneni, J.
Right arrow Articles by Yallampalli, C.
Agricola
Right arrow Articles by Penchalaneni, J.
Right arrow Articles by Yallampalli, C.
BIOLOGY OF REPRODUCTION 71, 1475–1483 (2004)
DOI: 10.1095/biolreprod.104.032086
© 2004 by the Society for the Study of Reproduction, Inc.


Pregnancy

Adrenomedullin Antagonist Treatment During Early Gestation in Rats Causes Fetoplacental Growth Restriction Through Apoptosis1

Josthna Penchalaneni3, Sunil J. Wimalawansa4, and Chandrasekhar Yallampalli2,3

Department of Obstetrics and Gynecology,3 University of Texas Medical Branch, Galveston, Texas 77555 Regional Bone Center,4 Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903

Adrenomedullin (AM), a potent vasorelaxant peptide, has been shown to function as an angiogenic and growth factor. The present study investigated whether antagonism of endogenous AM in rats during early gestation results in diminished placental and fetal growth and whether this occurs through induction of apoptosis. Rats on Gestational Day 8 were implanted s.c. with osmotic minipumps delivering 125 and 250 µg rat–1 day–1 of AM22–52 and were killed on Gestational Day 15. In AM22–52-treated rats, both placental and fetal weights were dose-dependently inhibited, with 50% reduction in the group receiving 250 µg rat–1 day–1. In these animals, fetal resorption sites were also increased. Apoptosis was demonstrated in placenta and uterus by the TUNEL method. Apoptotic changes were more apparent in trophoblast cells in the labyrinth zone of placenta and uterine decidua of AM22–52-treated rats when compared with vehicle-control rats. Immunoreactivity to active caspase-3 protein was abundant in the placenta and uterus of the AM22–52-treated group. Western blot analysis demonstrated that in homogenates of both the placenta and uterus of AM22–52-treated rats, levels of active caspase-9 and -3 as well as of Poly ADP ribose polymerase were significantly increased, whereas levels of Bcl-2 protein decreased, compared with controls. However, no significant treatment-associated changes were observed in Bid, Fas, Fas ligand, p53, and caspase-8 and -10 proteins in either placenta or uterus. Bad protein was undetectable in either tissue. In mitochondrial fractions from both placenta and uterus, the levels of Bax increased with decreases in cytochrome c on AM22–52 treatment. Conversely, in the cytosol, Bax levels decreased with increases in cytochrome c, demonstrating translocation of Bax from cytosol to mitochondria and release of cytochrome c from mitochondria with AM22–52 treatment. In conclusion, these findings show that antagonism of AM in rats during early pregnancy caused fetoplacental growth restriction through the activation of mitochondrial apoptotic pathways.

1 Supported by the NIH through grants HL-058144, HL-072650, and HD-40828.

2 Correspondence: Chandrasekhar Yallampalli, Department of Obstetrics & Gynecology, 301 University Blvd., MRB, Rm. 11.138, Galveston, TX 77555-1062. FAX: 409 747 0475; chyallam{at}utmb.edu




This article has been cited by other articles:


Home page
Biol. Reprod.Home page
Y.-Y. Li, L. Li, I. S.-S. Hwang, F. Tang, and W.-S. O
Coexpression of Adrenomedullin and Its Receptors in the Reproductive System of the Rat: Effects on Steroid Secretion in Rat Ovary
Biol Reprod, August 1, 2008; 79(2): 200 - 208.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Chauhan, U. Yallampalli, L. Reed, and C. Yallampalli
Adrenomedullin 2 Antagonist Infusion to Rats During Midgestation Causes Fetoplacental Growth Restriction Through Apoptosis
Biol Reprod, December 1, 2006; 75(6): 940 - 947.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A. Al-Ghafra, N.M. Gude, S.P. Brennecke, and R.G. King
Increased adrenomedullin protein content and mRNA expression in human fetal membranes but not placental tissue in pre-eclampsia
Mol. Hum. Reprod., March 1, 2006; 12(3): 181 - 186.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C.S. Thota, L.C. Reed, and C. Yallampalli
Effects of Parathyroid Hormone Like Hormone (PTHLH) Antagonist, PTHLH7-34, on Fetoplacental Development and Growth During Midgestation in Rats
Biol Reprod, December 1, 2005; 73(6): 1191 - 1198.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for the Study of Reproduction.